Seshu Tyagarajan - Chief Technology Officer at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technology Officer
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Seshu Tyagarajan - trading volume in the past year for Candel Therapeutics, Inc.

Holdings reported by Seshu Tyagarajan for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 85.5K $754K $8.82 Mar 17, 2025 Direct
Stock Option (Right to Buy) 70K Mar 17, 2025 Direct Common Stock

Transactions reported by Seshu Tyagarajan for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.